GSK and J&J file rheumatoid arthritis treatment sirukumab in EU
September 13, 2016Manufacturing and Production, Sales and Marketing GSK, GlaxoSmithKline, Johnson & Johnson, rheumatoid arthritis, sarilumab, sirukumab
GlaxoSmithKline and partner Johnson & Johnson’s Janssen Biologics unit have filed for approval of rheumatoid arthritis (RA) treatment sirukumab in …
Proteomics market to grow to $24.8 billion by 2024
September 13, 2016Manufacturing and Production, Research and Development Grand View Research, proteomics
The global proteomics market is predicted to grow to exceed $24.8 billion by 2024, according to a new report by …
Takeda forms “first of its kind” developmental partnership with CRO
September 13, 2016Manufacturing and Production, Research and Development PRA Health Services, Takeda, partnership
Takeda and PRA Health Services have announced a new partnership that will see the Japanese pharma giant transfer 300 staffers …
Horizon buys out Raptor for $800 million
September 13, 2016Manufacturing and Production, Sales and Marketing Horizon Pharma, Raptor Pharmaceutical, acquisition
Irish biopharmaceutical firm Horizon Pharma has finalised an $800 million deal to buy Raptor Pharmaceutical Corp in a bid to …
New Sanofi/Alphabet partnership names CEO
September 12, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alphabet, Sanofi, Verily, appointment, google
As part of the news that French drugmaker Sanofi and Google parent Alphabet’s life sciences firm Verily are to join …
ALS Pharma quadruples Cambridgeshire testing facility in £2m expansion
September 12, 2016Manufacturing and Production, Research and Development, Sales and Marketing ALS Pharmaceutical, Microbiology, expansion
UK microbiology and chemical analysis company ALS Pharmaceutical has quadrupled the size of its facility in Ely, Cambridgeshire as part …
Bayer ponders $1.1 billion portfolio sale to fund Monsanto acquisition
September 12, 2016Business Services, Manufacturing and Production, Sales and Marketing Bayer, acquisition, monsanto
In the latest development in the Bayer-Monsanto saga, the German drugmaker has enlisted the aid of global financial services firm …
GSK sells anaesthetic portfolio to Aspen for up to $372 million
September 12, 2016Sales and Marketing
GlaxoSmithKline is to sell its portfolio of anaesthetic drugs to South African firm Aspen Pharmacare in a deal worth up …
Clinton plan “negative for innovation”, says Pfizer CEO
September 12, 2016Sales and Marketing Hilary Clinton
Democrat presidential candidate Hilary Clinton’s plan to tackle “unjustified price hikes” outlined last week is “very negative for innovation”, according …
Sanofi and Google forge $500 million diabetes partnership
September 12, 2016Research and Development, Sales and Marketing Alphabet, Sanofi, Verily, diabetes, google
Sanofi is set to join forces with Alphabet’s life sciences firm Verily in a $500 million partnership to develop diabetes …
PCI Pharma Services to Share Expertise at Free Serialization Forum
September 9, 2016PCI Pharma Services
Leading pharmaceutical outsourcing services provider PCI Pharma Services, in collaboration with Xytnek, Antares, and Healthcare Packaging magazine, will host a …
Gilead appoints former Roche executive
September 9, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, Roche, appointment
Gilead Sciences has hired Rogers Luo as vice president and general manager of commercial operations in China. Luo formerly served …
Kymab demonstrates promising research for HIV vaccine development
September 9, 2016Medical Communications, Research and Development HIV, Vaccine, kymab
Cambridge-based antibodies-to-medicines company Kymab has announced publication of research testing the first step in the effort to develop effective vaccines …
GSK proposes biopreparedness unit to combat global outbreaks
September 9, 2016Medical Communications, Research and Development Ebola, GSK, Zika
London-based pharma giant GlaxoSmithKline has proposed the creation of a biopreparedness unit to help avert crises like those we have …
Top ten stories in the pharmaceutical industry this week
September 9, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, AstraZeneca, BMS, Celgene, Cloud Computing, Eisai, FDA, GSK, Halaven, Novartis, Novo Nordisk, Roche, Teva, agios, epipen, rheumatoid arthritis
It’s Friday, and that means it’s time for another run-down of the biggest stories on Pharmafile.com over the last week. …
Pfizer launches legal action to block Xeljanz copies in India
September 9, 2016Medical Communications, Sales and Marketing Pfizer, Sun Pharma, Xeljanz, Zydus Cadila, rheumatoid arthritis
Pfizer has pre-emptively sued a number of India-based drug companies including Sun Pharma and Zydus Cadila to block any attempts …
FDA approves Dechra’s generic antibiotic
September 9, 2016Medical Communications, Sales and Marketing Dechra, Putney, antiobiotic, generic
Dechra has announced that the US Food and Drug Administration (FDA) has approved its generic antibiotic. The product will be …
Apple introduce stricter entry requirements for health apps
September 8, 2016Medical Communications, Research and Development Apple, Guidelines, apps, iphone, strict
Apple has toughened its stance on health and medical apps that can be bought and downloaded on the iOS App …
Retrophin announces positive Phase II results, Shkreli claims credit
September 8, 2016Research and Development Phase II, Retrophin, Shkreli, rare kidney disease
Retrophin has announced positive top-line results for trial drug sparsentan in Phase II to treat a rare kidney disorder with …
Celgene and Agios to file FDA application for “first-in-class” cancer drug
September 8, 2016Research and Development, Sales and Marketing Celgene, FDA, NDA, acute myeloid leukaemia, agios
According to an SEC 8-K filing by Agios, the company and its partner Celgene intend to file a new drug …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
